Log In Sign up
The largest database of trusted experimental protocols

Pioglitazone

Manufactured by R&D Systems
Visit Supplier
Sourced in United States

Pioglitazone is a laboratory reagent used for research purposes. It is a thiazolidinedione compound that acts as a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist. This product is intended for use in in vitro research applications.

Automatically generated - may contain errors

Lab products found in correlation

T0070907, by R&D Systems (2 mentions) Wy 14643, by R&D Systems (1 mentions) Gw6471, by R&D Systems (1 mentions)

2 protocols using pioglitazone

1

PPARα and PPARγ Modulation in Osteogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Periosteal cells that had been cultured in osteogenic induction medium were treated with 0.1 to 25 µM PPARα agonist WY14643, 0.1 to 10 µM PPARγ agonist pioglitazone, 0.1 to 10 µM PPARα antagonist GW6471, or 0.1 to 10 µM PPARγ antagonist T0070907 (all from R&D Systems, Minneapolis, USA). Media were changed every 3 days and the ligands were also added at each change of the medium.
Hah Y.S., Joo H.H., Kang Y.H., Park B.W., Hwang S.C., Kim J.W., Sung I.Y., Rho G.J., Woo D.K, & Byun J.H. (2014). Cultured Human Periosteal-Derived Cells Have Inducible Adipogenic Activity and Can Also Differentiate Into Osteoblasts in a Perioxisome Proliferator-Activated Receptor-Mediated Fashion. International Journal of Medical Sciences, 11(11), 1116-1128.
+ Open protocol
+ Expand
2

Osteogenic Differentiation with PPARγ Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Periosteal cells that had been cultured in osteogenic induction medium were treated with 5 and 10 µM concentrations of either PPARγ agonist pioglitazone or PPARγ antagonist T0070907 (all from R&D Systems, Minneapolis, MN, USA). Media were changed every 3 days, and the PPARγ agonist or antagonist was also added at each change of the medium.
Chung J.E., Park J.H., Yun J.W., Kang Y.H., Park B.W., Hwang S.C., Cho Y.C., Sung I.Y., Woo D.K, & Byun J.H. (2016). Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling. International Journal of Medical Sciences, 13(11), 806-818.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!